Search Results

Displaying Results 5551-5575 of 5710 "'PM'"

Apr 28, 2025, 07:15 ET AWH to Hold First Quarter 2025 Earnings Conference Call on Monday, May 12, 2025

cannabis operator, today announced that it will hold a conference call on Monday, May 12, 2025, at 5:00 PM ET following the release of its first quarter 2025 financial results. The earnings conference call may be accessed by dialing 1-888-699-1199.

More news about: Ascend Wellness Holdings, Inc.

Apr 28, 2025, 07:00 ET Globe Life Inc. Announces First Quarter 2025 Earnings Release and Conference Call

A live conference call will broadcast on Thursday, May 1, 2025, at 12:00pm Eastern (11:00am Central) at 1-786-697-3501 (passcode: Globe Life Inc.) or online

More news about: Globe Life Inc.

Apr 28, 2025, 07:00 ET Rein Therapeutics Announces Abstract Accepted for Presentation at the American Thoracic Society 2025 International Conference

FibrosisDate & Time: Monday, May 19, 2025, at 11:30 AM PT/ 2:30 PM ET About Rein Therapeutics Rein Therapeutics is a clinical-stage biopharmaceutical company advancing a novel pipeline of

More news about: Rein Therapeutics, Inc.

Apr 28, 2025, 07:00 ET BETMGM 1Q 2025 BUSINESS UPDATE

audio webcast call will be held today, Monday April 28, 2025 at 9:00am EST (2:00pm UK), with participants able to join via webcast or by conference call.Live webcast link:

More news about: BetMGM

Apr 28, 2025, 06:15 ET Asetek - Q1 2025: Liquid cooling on track, soft start to year for SimSports

CEO André Sloth Eriksen and CFO Peter Dam Madsen will present the Company's results today at 1:30 pm CEST and invite investors, analysts and media to join the presentation. The presentation is expected to last up to one hour, including Q&A,

More news about: Asetek

Apr 28, 2025, 06:00 ET NetRise® Launches AI-Powered Cybersecurity Product To Detect Undisclosed Software Weaknesses Before They Become Exploited Vulnerabilities

ZeroLens.Happy Hour: RSVP now to join NetRise for HopSec Trivia Night on 4/29 at 5pm PT and Keys to Security: Dueling Piano Party on 4/30 at 5:30pm PT at The Grove, 690 Mission St, San Francisco, CA 94105. To attend

More news about: NetRise

Apr 28, 2025, 06:00 ET High Tide Reports Approximately $6.8 Million in Retail Sales During '4/20' Long Weekend

March 1, 2025, to April 20, 2025, with entries closing on 4/20 at 4:20 PM EDT. In light of recent events, and as a proudly Canadian company with over 1.8 million Cabana Club members across Canada,

More news about: High Tide Inc.

Apr 28, 2025, 06:00 ET Theravance to Present Analyses of Ampreloxetine and Neurogenic Orthostatic Hypotension at the 2025 International MSA Congress

9:40 AM EDTNorcliffe-Kaufmann L, et al. Poster #78 May 10, 2025 - 12:00 PM EDTImpact of symptomatic neurogenic orthostatic hypotension on symptom burden and daily functioning in patients with alpha

More news about: Theravance Biopharma, Inc.

Apr 28, 2025, 02:17 ET Oncoinvent Reports updated 18-Month Data from Phase 1 Ovarian Cancer Trial with Radspherin®: No new recurrences Demonstrate Continued Promise of Preventing Disease Progression

https://mb.cision.com/Main/15403/4141275/3412618.pdf 250425 Oncoinvent PM OC Ph1 18m

More news about: Oncoinvent AS

Apr 27, 2025, 23:07 ET James E. Malackowski Recognized with the Highest Honor in Intellectual Property Licensing

public accounting services. J.S. Held, its affiliates and subsidiaries are not law firms and do not provide legal advice. Securities offered through PM Securities, LLC, d/b/a Phoenix IB, a part of J.S. Held, member FINRA/ SIPC, or Ocean Tomo Investment Group, LLC, a part of J.S. Held, member FINRA/ SIPC.

More news about: J.S. Held

Apr 27, 2025, 22:00 ET 2025 AACR | Abbisko Therapeutics Presents Late-Breaking Pre-clinical Research Results on ABSK112 (EGFR exon20ins), ABSK131 (PRMT5*MTA), and ABK-KRAS-1

Experimental and Molecular Therapeutics 2 Session Date and Time: April 28, 2025, 2:00 PM - 5:00 PM (CDT) Location: Poster Section 54 Poster Board Number: 14 Poster Number: LB240 Conclusion:

More news about: Abbisko

Apr 27, 2025, 20:00 ET 2025 AACR | 信達生物多項創新雙抗、三抗及雙抗ADC臨床前數據亮相

標題： IBI3010，一種靶向FRα的雙表位ADC，用於治療FRα表達腫瘤的臨床前特性研究摘要號：LB222展示形式：壁報時間：2025年4月28日（星期一） 2：00 PM – 5：00 PM （當地時間）地點：Poster Section 53 IBI3010是一款靶向FRα的雙表位ADC，payload為新型拓撲異構酶I抑制劑NT1（DAR8）。其雙表位設計顯著增強了腫瘤結合與內吞。體外實驗顯示，IBI3010較Mirvetuximab

More news about: 信達生物

Apr 27, 2025, 20:00 ET 2025 AACR | Innovent Presents Preclinical Data of Multiple Novel Molecules including Bispecific and Tri-specific Antibodies and Bispecific ADCs

LB222Presentation Form: PosterPresentation Time: Monday April 28, 2025, 2:00 PM - 5:00 PMLocation: Poster Section 53 IBI3010 is a FRα targeting biparatopic ADC with novel topoisomerase I inhibitor NT1 (DAR8).

More news about: Innovent Biologics

Apr 25, 2025, 20:30 ET Antengene Presents Four Posters at AACR 2025 Highlighting Focuses on AnTenGagerTM TCEs and Synthetic Lethality

April 30, 2025Time: 9:00 AM - 12:00 PM (Central Time) 10:00 PM, April 30, 2025 - 1:00 AM, May

More news about: Antengene Corporation Limited

Apr 25, 2025, 17:24 ET Foundation for a Healthy St. Petersburg and Orlando Health Bayfront Hospital Launch New Grant

interested in applying for funding must submit letters-of-interest outlining their proposal and their confirmed partners by 5 PM on May 27, 2025. Collaborations invited to submit a full grant application will be informed the week of June

More news about: Foundation for a Healthy St. Petersburg

Apr 25, 2025, 16:19 ET Nanoscope Therapeutics Announces Participation at Eyecelerator® and ARVO 2025 Annual Meetings

participation: 12:30 – 1:30pm MDT – Panel – I Shall be Released: Novel Drug Delivery Approaches for Glaucoma and Retina – Dr. Sam Barone, Chief Medical Officer1:59 – 2:04pm MDT; Strawberry Ballroom – Presenting Company

More news about: Nanoscope Therapeutics

Apr 25, 2025, 14:45 ET BillionToOne to Present New Data at AACR Annual Meeting 2025

9:00 AM - 12:00 PMLocation: Poster Section 20 Title: "Detection of a novel GNA11 processed pseudogene from cfDNA and implications for liquid biopsy"Session Time: 4/29/25 at 2:00 - 5:00 PMLocation:

More news about: BillionToOne

Apr 25, 2025, 14:02 ET Last Chance for Animals Supports Councilmember Blumenfield's Motion to Halt Elephant Transfer to Tulsa Zoo

holding a peaceful demonstration at the L.A. Zoo on Sunday, April 27, from 11:00 AM to 2:00 PM to fight for Billy and Tina and advocate for their transfer to an elephant sanctuary. About Last Chance for Animals (LCA)LCA

More news about: Last Chance For Animals

Apr 25, 2025, 13:15 ET CoreWeave Announces Date of First Quarter 2025 Financial Results

14, 2025. CoreWeave will also host a conference call to discuss its results at 2:00 pm Pacific Time / 5:00 pm Eastern Time. The live webcast of the earnings conference call can be accessed at the CoreWeave Investor Relations website

More news about: CoreWeave

Apr 25, 2025, 13:00 ET Marengo to Share Updated Clinical Results from STARt-001 Phase 1/2 Clinical Trial Featuring Invikafusp Alfa Monotherapy Activity in PD1 Resistant Tumors at Upcoming AACR 2025 Clinical Plenary Oral Presentation

EngagersSession Date and Time: Tuesday, April 29, 2025, 10:15 AM – 12:15 PM CTPresenter: Ryan J. Sullivan, M.D., Massachusetts General HospitalAbout Marengo

More news about: Marengo Therapeutics

Apr 25, 2025, 12:02 ET Bexion Pharmaceuticals, Inc. Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2025

2025Session Time: 2:00 PM - 5:00 PMPresenter: Dr. Tariq Arshad The abstracts are scheduled to be posted to the AACR Online Program Planner at 4:30 PM ET on Tuesday, March 25. About

More news about: Bexion Pharmaceuticals, Inc.

Apr 25, 2025, 11:04 ET Dreame Technology Unveils Strategic New Smart Home Lineup and Officially Opens First MEA Flagship Store

Vacuum, featuring the first AI-powered robotic arm for gap-free cleaning; and other standout products like the Z30 Cordless Stick Vacuum, AirStyle Pro, and PM20 Air Purifier. Behind these innovations lies the technology that powers them. Dreame's breakthroughs are driven by world-class high-speed digital motors

More news about: Dreame Technology

Apr 25, 2025, 10:20 ET CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU

https://assets.hpra.ie/products/Human/22656/Licence_PA0896-028-005_03012024152159.pdfThis information was submitted for publication at 4:00 pm CET on 25 April 2025. This information was brought to you by Cision

More news about: Camurus AB

Apr 25, 2025, 10:15 ET CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU